the

initiative

ReLeef

The global healthcare systems are challenged by a dramatic shift in population health dynamics.

 

In regards to HIV/AIDS, the use of antiviral drugs has increased significantly. This has resulted in an increased demand for treatments for secondary complications such as infections and metabolic diseases.

 

Our organization is developing an innovative new therapeutic product that addresses tissue wasting in HIV/AIDS.

We represent a new kind of organization

that combines a humanitarian purpose with a state-of-the-art industrial approach

A radically new healthcare product to combat tissue wasting in severe infections...